Vialwirebiotech, curated
October 2, 2026, 9:39 AM
June 22, 2026
- 9:34 AM · PharmaVoice9:34 AMPfizer CFO departs for consumer goods sector — PharmaVoice
- 9:21 AM · PharmaVoice9:21 AMBacked by Sanofi and Roche, Orano Med chases radiopharma leadership — PharmaVoice
- 9:00 AM · BioWorld9:00 AMBioarctic and Lilly partner in neurodegeneration — BioWorld
- 9:00 AM · BioWorld9:00 AMGrant supports Replicate’s srRNA vaccine development for TB — BioWorld
- 7:49 AM · BioPharma Dive7:49 AMAbbVie to acquire Apogee, staking nearly $11B on long-acting autoimmune drugs — BioPharma Dive
- 6:00 AM · Drug Discovery World6:00 AMElicio refines its Phase III strategy for ELI-002 7P in pancreatic cancer — Drug Discovery World
- 5:03 AM · Pharmaceutical Technology5:03 AMSun Pharma to acquire Innovcare Lifesciences for $28.7m — Pharmaceutical Technology
- 4:10 AM · Drug Discovery World4:10 AMProtillion and Merck unveil drug discovery collaboration — Drug Discovery World
- 4:01 AM · Pharmaceutical Technology4:01 AMJapan approves Sanofi’s Sarclisa combo for MM treatment — Pharmaceutical Technology
- 2:53 AM · STAT News2:53 AMSTAT+: Sanofi names new R&D head as it tries to jumpstart pipeline — STAT News
June 21, 2026
- 12:00 AM · FT — Pharmaceuticals12:00 AMCancer drugmaker Revolution Medicines says sale not a priority — FT — Pharmaceuticals
- 12:00 AM · FT — Pharmaceuticals12:00 AMCancer drugmaker Revolution Medicines says sale not a priority — FT — Pharmaceuticals